Nachrichten zur Amgen Inc. Aktie

Amgen: Kursziel angehoben

Minneapolis (www.aktiencheck.de) - Rating-Update: Die Analysten von Piper Sandler belassen die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900, Ticker-Symbol: AMG,…

The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space

Wall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss…

The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca

Eli Lilly, Novo Nordisk, Amgen and AstraZeneca are included in this Analyst Blog.…

Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report

…

Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza

Xeris (XERS) gains 16% after signing a licensing deal with Amgen, which allows the latter to utilize the XeriJect technology…

Xeris Biopharma inks exclusive worldwide license agreement with Amgen for XeriJect in thyroid eye disease

Xeris Biopharma Holdings (NASDAQ:XERS) announced an exclusive worldwide license agreement with Amgen for the development, manufacturing, and...…

Kurs von Amgen fällt ab (281,2317 €)

An der US-amerikanischen Börse notiert die Amgen-Aktie derzeit ein wenig leichter. Das Wertpapier kostete zuletzt 307,15 US-Dollar. Ein Minus von…

Amgen Inc. (AMGN) Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024 (Transcript)

…

Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships

Nvidia is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships with Amgen and Recursion Pharmaceuticals.…

Global Antibody Therapeutic Market Research Report 2024-2033 Featuring Key Players - AbbVie, Amgen, Johnson & Johnson Services, Eli Lilly and Co, and Hoffmann-La Roche

Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route…

Amgen: Neues Allzeithoch! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Amgen-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

VIRICA Index gibt Vollgas: Regeneron, Amgen und Vertex auf Rekordhoch

Die Aktien der amerikanischen Biotech-Riesen Vertex Pharmaceuticals, Amgen und Regeneron haben einen bärenstarken Start ins Börsenjahr 2024 hingelegt. Alle drei…

wikifolio whispers a.m. Amgen, Talanx, Apple ...

Amgen 1.85% TomTrades (EMT01): $AMGN sieht aus als würde es ausbrechen, mit gutem Volumen und einer starken Performance, vor allem…

Schlussglocke: Indizes schließen in der Nähe ihrer Tagestiefs – Fed-Protokoll hilft nur kurz – Chevron, Amgen stark – Tesla unter Druck

ach dem ernüchternden Jahresstart vor allem für Technologiewerte haben die US-Börsen auch am Mittwoch nachgegeben. Die Veröffentlichung des jüngsten Sitzungsprotokolls…

Amgen analysts boost target price on obesity drug data outlook

Amgen Inc (NASDAQ:AMGN, ETR:AMG) stock is poised to move higher in 2024 on a thesis its Phase II drug AMG133…

Aktienmarkt: Kurs der Aktie von Amgen im Plus (257,5249 €)

Der Anteilsschein von Amgen notiert heute etwas fester. Das Papier kostete zuletzt 286,19 US-Dollar. Freuen können sich gegenwärtig die Aktionäre…

LegoChem signs antibody deal with Amgen worth up to $1.25B

…

FDA Rejects Amgens (AMGN) NDA Seeking Full Nod for Lumakras

Per the FDA, Amgen (AMGN) will need to complete an additional confirmatory study on Lumakras in certain lung cancer patients…

Amgen’s NDA for Lumakras cancer treatment resulted in complete response letter

…

Amgen: Kurszielerhöhung

Tokio (www.aktiencheck.de) - Rating-Update: Narumi Nakagiri, Analyst von Daiwa Capital Markets, stuft die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900,…

Global Biologics Drug Discovery Market Analysis, 2023-2033: Dominated by AbbVie, Amgen, AstraZeneca, and Pfizer

Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Biologics Drug Discovery Market - A Global and Regional Analysis,…

Amgen shares rise as analysts see ‘value obesity play’

…

Amgen: Hochstufung und neues Kursziel - Aktienanalyse

Toronto (www.aktiencheck.de) - Amgen-Aktienanalyse von BMO Capital Markets: Evan Seigerman, Analyst von BMO Capital Markets, stuft in einer aktuellen Aktienanalyse die…

Amgen lifted at BMO Capital as analysts see 22% potential upside By Investing.com

Amgen lifted at BMO Capital as analysts see 22% potential upside…

Stocks making the biggest moves premarket: Amgen, Sunnova, Arvinas and more

These are the stocks posting the largest moves in premarket trading.…

wikifolio whispers a.m. Intel, McDonalds, Amgen und Deutsche Boerse

Intel 0.31% Silberpfeil60 (BLKCHN): Intel sagt, dass Dutzende von PC-Herstellern seinen neuen KI-fähigen Chip verwenden Intel https://de.tradingview.com/symbols/NASDAQ-INTC/ sagte am Donnerstag,…

AbbVie, Amgen among firms targeted for latest Medicare inflation penalties

…

Breast Cancer Drugs Global Market Report 2024, Featuring Profiles of Key Players Novartis, AstraZeneca, Eli Lilly, Biocon, Merck and MacroGenics

Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added…

Amgen: Kursziel gesenkt

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley stufen die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900, Ticker-Symbol:…

Amgens (AMGN) Tarlatamab BLA Gets FDA Priority Tag for SCLC

Amgens (AMGN) BLA for tarlatamab to treat advanced small cell lung cancer gets FDAs priority review. A decision is expected…

1 Biotech Stock That Could Be the Next Amgen

The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen.…

Top 5 NASDAQ Biotech Stocks of 2023

This year the NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has slowly tracked downward in response to the high volatility seen across global…

Amgen raises dividend to $2.25 a share

…

: Amgen raises dividend to $2.25 a share

Amgen Inc. AMGN said late Tuesday its board has authorized a dividend of $2.25 a share, up from $2.13 a…

Amgen upgraded at RBC on catalyst setup and growth drivers

…

IBM, Nike, Amgen and Salesforce are catalysts as Dow industrials pivot to gain

IBM, Nike, Amgen and Salesforce are catalysts as Dow industrials pivot to gain…

Amgen: Neue Wachstumschancen - Aktienanalyse

Toronto (www.aktiencheck.de) - Amgen-Aktienanalyse von RBC Capital Markets: Gregory Renza, Analyst vom Investmenthaus RBC Capital Markets, stuft die Aktie von Amgen…

RBC Capital upgrades Amgen on improving position of stability and diminishing uncertainty By Investing.com

RBC Capital upgrades Amgen on improving position of stability and diminishing uncertainty…

ARWR: Updates on Plozasiran and Zodasiran at AHA 2023…

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Updated Clinical Data for Cardiometabolic Candidates Presented at AHA 2023 On November…

KRAS Inhibitors Market Current Trends and Future Scope Analysis Report

Companies covered in this report are Amgen, Boehringer Ingelheim, BridgeBio Pharma, Erasca, Innovent Biologics Inc., Incyte, Mirati Therapeutics, Novartis, Jemincare,…

Multiple Myeloma Market revenue to surpass USD 71 Billion by 2035, says Research Nester

Major multiple myeloma market players include Amgen Inc., Johnson & Johnson, Takeda Pharmaceuticals Company Limited, Novartis AG, Sanofi, Teva Pharmaceuticals…

Global Melanoma Therapeutics Market Size To Worth USD 12.35 Billion By 2032 | CAGR of 9.4%

The Global Melanoma Therapeutics Market Size was valued at USD 5.03 Billion in 2022 and the Worldwide Melanoma Therapeutics Market…

Pro Research: Wall Street takes on Amgens diverse prospects By Investing.com

Pro Research: Wall Street takes on Amgens diverse prospects…

Amazon (AMZN) Teams Up With Amgen, Expands Customer Base

Amazons (AMZN) AWS gets selected by Amgen. This highlights the efficiency and reliability of AWS innovative cloud products and services.…

Amgen Inc. (AMGN) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)

…

Pancreatic Cancer Market revenue to reach USD 36 Billion by 2036, says Research Nester

Key pancreatic cancer market players include Amgen Inc., Novartis AG, Pfizer Inc., Aduro Biotech Inc., Clovis Oncology Inc., NewLink Genetics…

Non-Oncology Biologics and Biosimilars Market is Booming and Expected to Grow at a CAGR of 21.8% to 2031

Companies covered in this report are AbbVie Inc., Sanofi, Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La…

Top Stock Reports for McDonalds, Amgen & NextEra Energy

Todays Research Daily features new research reports on 16 major stocks, including McDonalds Corporation (MCD), Amgen Inc. (AMGN) and NextEra…

Amazon Web Services, Amgen to work on generative AI solutions to advance therapies

…

Pro Research: Wall Street dives into Amgens strategic shifts By Investing.com

Pro Research: Wall Street dives into Amgens strategic shifts…